Papers: 10.1038/s41389-018-0096-9

https://doi.org/10.1038/s41389-018-0096-9

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

Cited by: 38
Author(s): Veronique L. Veenstra, Helene Damhofer, Cynthia Waasdorp, L.B. van Rijssen, Marc J. van de Vijver, Frederike Dijk, Hanneke Wilmink, Marc G. Besselink, Olivier R. Busch, David K. Chang, Peter J. Bailey, Andrew V. Biankin, Hemant M. Kocher, Jan Paul Medema, J. S. Li, Rou Jiang, Daniel W. Pierce, Hanneke W. M. van Laarhoven, Maarten F. Bijlsma
Published: almost 8 years ago

Software Mentions 1